Monday · Sepsis & Shock
September 7, 2026
INSPIRE: Precision Immunotherapy Delivers Another Positive Signal in Sepsis
The December 2025 Lancet Regional Health Europe phase IIa trial by Tavoulareas, Giamarellos-Bourboulis, and colleagues at the Hellenic Institute for the Study of Sepsis randomized 60 hospitalized adults with community-acquired…
Read on Substack →